The November 12 restrictions on hemp-derived THC beverages may have unintended consequences for public health. Amanda Parker argues that Congress should pursue responsible regulation focused on safety, consumer protection, and harm reduction rather than restricting access to products that many adults use as an alternative to alcohol.

AACPN applauds Connecticut’s enactment of Public Act 26-108, expanding the state’s psychedelic-assisted therapy pilot program and supporting continued clinical research involving MDMA and psilocybin therapies for veterans, first responders, trauma survivors, and individuals living with treatment-resistant mental health conditions.